These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2908399)

  • 1. [Glucocerebrosidase deficiency--Gaucher's disease].
    Tsuji S
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):728-33. PubMed ID: 2908399
    [No Abstract]   [Full Text] [Related]  

  • 2. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.
    Tsuji S; Choudary PV; Martin BM; Stubblefield BK; Mayor JA; Barranger JA; Ginns EI
    N Engl J Med; 1987 Mar; 316(10):570-5. PubMed ID: 2880291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight linkage between type III Gaucher's disease (Norrbottnian type) and a MspI polymorphism within the gene for human glucocerebrosidase.
    Dahl N; Erikson A; Hammarström-Heeroma K; Pettersson U
    Genomics; 1988 Nov; 3(4):296-8. PubMed ID: 2468600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher's disease: advances and challenges.
    Martin BM; Sidransky E; Ginns EI
    Adv Pediatr; 1989; 36():277-306. PubMed ID: 2675571
    [No Abstract]   [Full Text] [Related]  

  • 5. Gaucher's disease.
    Beaudet AL
    N Engl J Med; 1987 Mar; 316(10):619-21. PubMed ID: 3807955
    [No Abstract]   [Full Text] [Related]  

  • 6. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
    Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
    Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology of glucocerebrosidase and the treatment of Gaucher disease.
    Barranger JA; Tomich J; Weiler S; Sakallah S; Sansieri C; Mifflin T; Bahnson A; Wei FS; Wei JF; Vallor M
    Cytokines Mol Ther; 1995 Sep; 1(3):149-63. PubMed ID: 9384672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrovirus-mediated transfer of the human glucocerebrosidase gene to Gaucher fibroblasts.
    Choudary PV; Barranger JA; Tsuji S; Mayor J; LaMarca ME; Cepko CL; Mulligan RC; Ginns EI
    Mol Biol Med; 1986 Jun; 3(3):293-9. PubMed ID: 3736391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
    Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP
    Nature; 1992 Jun; 357(6377):407-10. PubMed ID: 1594045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel frameshift mutation (Pro171fsX21) in neonatal type 2 Gaucher's disease.
    Park HW; Lee Y; Kim GH; Lee BS; Kim KS; Yoo HW; Kim EA
    Gene; 2012 Oct; 507(2):170-3. PubMed ID: 22772462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder.
    Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E
    J Clin Invest; 1990 Jan; 85(1):219-22. PubMed ID: 2295698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetics of Gaucher's disease. Genotype-phenotype correlation].
    Alfonso Palacín P; Pocoví M
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():17-22. PubMed ID: 22230121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA analysis of an uncommon missense mutation in a Gaucher disease patient of Jewish-Polish-Russian descent.
    Choy FY; Wei C; Applegarth DA; McGillivray BC
    Am J Med Genet; 1994 Jun; 51(2):156-60. PubMed ID: 7916532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of severity of Gaucher's disease by identification of mutations at DNA level.
    Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E
    Lancet; 1989 Aug; 2(8659):349-52. PubMed ID: 2569551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
    Fabrega S; Lehn P
    J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous loss of a cysteine residue in the glucocerebrosidase gene results in Gaucher's disease with a hydropic phenotype.
    Church HJ; Cooper A; Stewart F; Thornton CM; Wraith JE
    Eur J Hum Genet; 2004 Nov; 12(11):975-8. PubMed ID: 15292921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isozymes of beta-glucosidase: determination of Gaucher's disease phenotypes.
    Ginns EI; Erickson A; Tegelaers FP; Barneveld R; Reuser AJ; Brady RO; Tager JM; Barranger JA
    Isozymes Curr Top Biol Med Res; 1983; 11():83-93. PubMed ID: 6417048
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gaucher's disease: pathogenesis, diagnosis and therapy].
    Pregun I; Tulassay Z
    Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in type I Gaucher disease demonstrated by restriction mapping of the gene.
    Sorge J; Gelbart T; West C; Westwood B; Beutler E
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5442-5. PubMed ID: 2991926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease.
    Orvisky E; Park JK; Parker A; Walker JM; Martin BM; Stubblefield BK; Uyama E; Tayebi N; Sidransky E
    Hum Mutat; 2002 Apr; 19(4):458-9. PubMed ID: 11933202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.